Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphatic absorption during peritoneal dialysis.

K D Nolph1

  • 1University of Missouri Health Sciences Center, Dalton Research Center, Columbia.

Advances in Experimental Medicine and Biology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A reply to Dr. Charles Schleifer about "PD First".

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2007
Same author

Serum insulin-like growth factor I levels do not correlate with residual renal function in dialysis patients.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2002
Same author

Cardiovascular comorbidity and mortality in patients starting peritoneal dialysis: an American midwestern center experience.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2001
Same author

Past, present, and future of quantified peritoneal dialysis.

Seminars in dialysis·2001
Same author

Peritoneal dialysis should be the first choice of initial renal replacement therapy for more patients with end-stage renal disease.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2001
Same author

Argument for timely initiation of dialysis.

Journal of the American Society of Nephrology : JASN·2001

Lymphatic absorption significantly reduces ultrafiltration. Drugs that decrease lymphatic absorption may enhance ultrafiltration, drainage volume, and solute clearance, offering an alternative to hypertonic dextrose exchanges.

Area of Science:

  • Nephrology
  • Pharmacology
  • Physiology

Background:

  • Ultrafiltration is crucial for fluid and solute removal in peritoneal dialysis.
  • Lymphatic absorption is a key factor influencing ultrafiltration efficiency.
  • Current methods to enhance ultrafiltration often rely on hypertonic dextrose exchanges.

Purpose of the Study:

  • To investigate the role of lymphatic absorption in ultrafiltration kinetics.
  • To explore the potential of drugs decreasing lymphatic absorption to improve ultrafiltration.
  • To evaluate an alternative strategy for enhancing net ultrafiltration.

Main Methods:

  • Analysis of existing studies on lymphatic absorption and ultrafiltration.
  • Review of pharmacological agents affecting lymphatic transport.

Related Experiment Videos

  • Comparative assessment of ultrafiltration enhancement strategies.

    • Main Results:

    • Lymphatic absorption significantly reduces net ultrafiltration.
    • Drugs inhibiting lymphatic absorption increase net ultrafiltration, drainage volume, and solute clearances.
    • This approach may reduce reliance on hypertonic dextrose.

    Conclusions:

    • Lymphatic absorption is a major determinant of ultrafiltration.
    • Pharmacological inhibition of lymphatic absorption presents a promising strategy to enhance peritoneal dialysis outcomes.
    • This offers a potential alternative to conventional methods for improving fluid and solute removal.